These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4872692)

  • 41. [Treatment of mental disorders with high-dosage reserpine (serpasil) and chlorpromazine (largactil)].
    BELSASSO M
    Rass Giuliana Med; 1956 Jul; 12(7):209-16. PubMed ID: 13389800
    [No Abstract]   [Full Text] [Related]  

  • 42. [Reserpine in psychiatric therapy; comments and new theories concerning the use of neuroleptic drugs].
    BRISSET F
    Encephale; 1958; 47(6):486-548. PubMed ID: 13619544
    [No Abstract]   [Full Text] [Related]  

  • 43. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 44. The clinical use of reserpine and chlorpromazine in the care of the mentally deficient.
    JOHNSTON AH; MARTIN CH
    Am J Ment Defic; 1957 Sep; 62(2):292-4. PubMed ID: 13458230
    [No Abstract]   [Full Text] [Related]  

  • 45. GABA and movement disorders.
    Marsden CD; Sheehy MP
    Adv Biochem Psychopharmacol; 1981; 30():225-34. PubMed ID: 6460427
    [No Abstract]   [Full Text] [Related]  

  • 46. Single and repeat dose effects of imipramine and chlorpromazine in man.
    Irwin S; Konohi RG
    Psychopharmacol Bull; 1971 Oct; 7(4):23-4. PubMed ID: 4940445
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the antagonism between neuroleptic and thymoleptic drugs in psychiatry and neurology].
    Kirow K
    Z Arztl Fortbild (Jena); 1965 Nov; 59(21):1142-5. PubMed ID: 5329770
    [No Abstract]   [Full Text] [Related]  

  • 48. Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(5):367-70. PubMed ID: 4998432
    [No Abstract]   [Full Text] [Related]  

  • 49. [Increase in resistance of mice toward acute hypoxia by means of apressin in combination with other compounds].
    Lukienko PI; Korablev MV
    Farmakol Toksikol; 1970; 33(3):343-5. PubMed ID: 5453033
    [No Abstract]   [Full Text] [Related]  

  • 50. [Supportive and ambulatory treatment with neuroleptic drugs; review of foreign literature published during 1955-57].
    LEVIT VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(9):1178-83. PubMed ID: 13531954
    [No Abstract]   [Full Text] [Related]  

  • 51. Two-year observation on the treatment of mental diseases with chlorpromazine and reserpine.
    BUKOWCZYK A
    Pol Tyg Lek (Wars); 1957 Sep; 12(38):1448-51. PubMed ID: 13505242
    [No Abstract]   [Full Text] [Related]  

  • 52. [24 Chronic mental patients treated successively with prolonged chlorpromazine therapy followed by reserpine; comparative results; superior effect of reserpine in hypomanic syndromes].
    LAMBERT PA; TOULET M; DIEDERICHS A; LEMONNIER J
    Ann Med Psychol (Paris); 1957 Jul; 115(2):284-90. PubMed ID: 13458950
    [No Abstract]   [Full Text] [Related]  

  • 53. [A new treatment in current psychiatric practice: Sedalium].
    Dubois JC; Dacharry JC; Demoures JM
    Ann Med Psychol (Paris); 1970 Feb; 1(2):276-93. PubMed ID: 5433571
    [No Abstract]   [Full Text] [Related]  

  • 54. Anticholinergics and psychiatric practice.
    Sajadi C
    Tex Med; 1979 Jul; 75(7):41-4. PubMed ID: 473093
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
    Dimitrov DA
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):342-3. PubMed ID: 5897865
    [No Abstract]   [Full Text] [Related]  

  • 56. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Neurology; 1970 Apr; 20(4):376-7. PubMed ID: 4935022
    [No Abstract]   [Full Text] [Related]  

  • 57. Alcohol-chlorpromazine interaction in psychiatric patients.
    Forrest FM; Forrest IS; Finkle BS
    Agressologie; 1972; 13(1):67-74. PubMed ID: 5073656
    [No Abstract]   [Full Text] [Related]  

  • 58. The use of reserpine and chlorpromazine in disturbed mentally deficient patients.
    WARDELL DW; RUBIN HK; ROSS RT
    Am J Ment Defic; 1958 Sep; 63(2):330-44. PubMed ID: 13571286
    [No Abstract]   [Full Text] [Related]  

  • 59. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment: side effects and clinical laboratory findings.
    Kurland AA; Bethon GD; Michaux MH; Agallianos DD
    J New Drugs; 1966; 6(2):80-95. PubMed ID: 5331284
    [No Abstract]   [Full Text] [Related]  

  • 60. Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults.
    Veening GJ
    Bull Int Union Tuberc; 1968 Dec; 41():169-71. PubMed ID: 4885378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.